Halozyme Therapeutics Inc (HALO) Stock Price, Chart, News and AI analysis



HALO

HALO Price

Halozyme Therapeutics Inc

$66.41

3.57%

$2.28

At close: May 11, 16:00:00 GMT-4

$69.08

4.02%

$2.67

Post-market: May 11, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$64.12

Open

$63.25

Day's Range

$63.25 - $69.08

52 week range

$47.5 - $82.22

Volume

2.5M

Avg.Volume

1.6M

Dividend yield

EPS (TTM)

2.49

Market Cap

$8.1B

What is HALO?

The company is headquartered in San Diego, California and currently employs 423 full-time employees. The company went IPO on 2003-01-30.

Features

Markets

News

No Data Yet

Supported by

+5.96%

+8%

30D

+9.14%

-2.88%

YTD

-4.01%

+5.96%

+8%

30D

+9.14%

-2.88%

YTD

-4.01%

Follow-Up Questions

What is Halozyme Therapeutics Inc (HALO)'s P/E Ratio?



The P/E ratio of Halozyme Therapeutics Inc is 23.9125

Who is the CEO of Halozyme Therapeutics Inc?



Dr. Helen Torley is the President of Halozyme Therapeutics Inc, joining the firm since 2014.

What is the price performance of HALO stock?



The current price of HALO is $69.08, it has increased 4.02% in the last trading day.

What are the primary business themes or industries for Halozyme Therapeutics Inc?



Halozyme Therapeutics Inc belongs to Biotechnology industry and the sector is Health Care

What is Halozyme Therapeutics Inc market cap?



Halozyme Therapeutics Inc's current market cap is $8.1B

Is Halozyme Therapeutics Inc a buy, sell, or hold?



According to wall street analysts, 11 analysts have made analyst ratings for Halozyme Therapeutics Inc, including 2 strong buy, 9 buy, 4 hold, 0 sell, and 2 strong sell

Follow-Up Questions

What is Halozyme Therapeutics Inc (HALO)'s P/E Ratio?



The P/E ratio of Halozyme Therapeutics Inc is 23.9125

Who is the CEO of Halozyme Therapeutics Inc?



Dr. Helen Torley is the President of Halozyme Therapeutics Inc, joining the firm since 2014.

What is the price performance of HALO stock?



The current price of HALO is $69.08, it has increased 4.02% in the last trading day.

What are the primary business themes or industries for Halozyme Therapeutics Inc?



Halozyme Therapeutics Inc belongs to Biotechnology industry and the sector is Health Care

What is Halozyme Therapeutics Inc market cap?



Halozyme Therapeutics Inc's current market cap is $8.1B

Is Halozyme Therapeutics Inc a buy, sell, or hold?



According to wall street analysts, 11 analysts have made analyst ratings for Halozyme Therapeutics Inc, including 2 strong buy, 9 buy, 4 hold, 0 sell, and 2 strong sell

Halozyme Therapeutics Inc (HALO) Price

HALO Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is HALO?

Related News

Halozyme Q1 earnings jump 42%, co announces $1B buyback

Follow-Up Questions

What is Halozyme Therapeutics Inc (HALO)'s P/E Ratio?

Who is the CEO of Halozyme Therapeutics Inc?

What is the price performance of HALO stock?

What are the primary business themes or industries for Halozyme Therapeutics Inc?

What is Halozyme Therapeutics Inc market cap?

Is Halozyme Therapeutics Inc a buy, sell, or hold?

Related News

Halozyme Q1 earnings jump 42%, co announces $1B buyback

Follow-Up Questions

What is Halozyme Therapeutics Inc (HALO)'s P/E Ratio?

Who is the CEO of Halozyme Therapeutics Inc?

What is the price performance of HALO stock?

What are the primary business themes or industries for Halozyme Therapeutics Inc?

What is Halozyme Therapeutics Inc market cap?

Is Halozyme Therapeutics Inc a buy, sell, or hold?